##gff-version 3
##sequence-region Q8N884 1 522
Q8N884	UniProtKB	Chain	1	522	.	.	.	ID=PRO_0000089543;Note=Cyclic GMP-AMP synthase	
Q8N884	UniProtKB	Nucleotide binding	225	227	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:6CTA,ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Nucleotide binding	376	383	.	.	.	Note=GTP;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:24462292;Dbxref=PMID:24462292	
Q8N884	UniProtKB	Nucleotide binding	380	383	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:6CTA,ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Nucleotide binding	435	439	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000305;evidence=ECO:0000244|PDB:6CTA,ECO:0000269|PubMed:30007416,ECO:0000305|PubMed:24462292;Dbxref=PMID:30007416,PMID:24462292	
Q8N884	UniProtKB	Region	1	160	.	.	.	Note=DNA-binding;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28363908;Dbxref=PMID:28363908	
Q8N884	UniProtKB	Region	120	160	.	.	.	Note=Required for activation upon DNA viral infection;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Region	173	215	.	.	.	Note=DNA-binding;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000305;evidence=ECO:0000244|PDB:6CTA,ECO:0000269|PubMed:30007416,ECO:0000305|PubMed:23707061;Dbxref=PMID:30007416,PMID:23707061	
Q8N884	UniProtKB	Region	384	407	.	.	.	Note=DNA-binding;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:23707061;Dbxref=PMID:23707061	
Q8N884	UniProtKB	Motif	295	305	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30356214;Dbxref=PMID:30356214	
Q8N884	UniProtKB	Metal binding	225	225	.	.	.	Note=Magnesium%3B catalytic;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000305,ECO:0000305;evidence=ECO:0000244|PDB:6CT9,ECO:0000244|PDB:6CTA,ECO:0000269|PubMed:30007416,ECO:0000305|PubMed:23722159,ECO:0000305|PubMed:26229115;Dbxref=PMID:30007416,PMID:23722159,PMID:26229115	
Q8N884	UniProtKB	Metal binding	227	227	.	.	.	Note=Magnesium%3B catalytic;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000305,ECO:0000305;evidence=ECO:0000244|PDB:6CT9,ECO:0000244|PDB:6CTA,ECO:0000269|PubMed:30007416,ECO:0000305|PubMed:23722159,ECO:0000305|PubMed:26229115;Dbxref=PMID:30007416,PMID:23722159,PMID:26229115	
Q8N884	UniProtKB	Metal binding	319	319	.	.	.	Note=Magnesium%3B catalytic;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:6CT9,ECO:0000244|PDB:6CTA,ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Metal binding	390	390	.	.	.	Note=Zinc%3B via tele nitrogen;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5V8H,ECO:0000244|PDB:5V8J,ECO:0000244|PDB:5V8O,ECO:0000244|PDB:5VDO,ECO:0000244|PDB:5VDP,ECO:0000244|PDB:5VDQ,ECO:0000244|PDB:5VDR,ECO:0000244|PDB:5VDS,ECO:0000244|PDB:5VDT,ECO:0000244|PDB:5VDU,ECO:0000244|PDB:5VDV,ECO:0000244|PDB:5VDW,ECO:0000244|PDB:6CT9,ECO:0000244|PDB:6CTA,ECO:0000244|PDB:6NAO,ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:24332030,ECO:0000269|PubMed:24462292,ECO:0000269|PubMed:28934246,ECO:0000269|PubMed:28940468,ECO:0000269|PubMed:30007416;Dbxref=PMID:23707061,PMID:24332030,PMID:24462292,PMID:28934246,PMID:28940468,PMID:30007416	
Q8N884	UniProtKB	Metal binding	396	396	.	.	.	Note=Zinc;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5V8H,ECO:0000244|PDB:5V8J,ECO:0000244|PDB:5V8O,ECO:0000244|PDB:5VDO,ECO:0000244|PDB:5VDP,ECO:0000244|PDB:5VDQ,ECO:0000244|PDB:5VDR,ECO:0000244|PDB:5VDS,ECO:0000244|PDB:5VDT,ECO:0000244|PDB:5VDU,ECO:0000244|PDB:5VDV,ECO:0000244|PDB:5VDW,ECO:0000244|PDB:6CT9,ECO:0000244|PDB:6CTA,ECO:0000244|PDB:6NAO,ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:24332030,ECO:0000269|PubMed:24462292,ECO:0000269|PubMed:28934246,ECO:0000269|PubMed:28940468,ECO:0000269|PubMed:30007416;Dbxref=PMID:23707061,PMID:24332030,PMID:24462292,PMID:28934246,PMID:28940468,PMID:30007416	
Q8N884	UniProtKB	Metal binding	397	397	.	.	.	Note=Zinc;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5V8H,ECO:0000244|PDB:5V8J,ECO:0000244|PDB:5V8O,ECO:0000244|PDB:5VDO,ECO:0000244|PDB:5VDP,ECO:0000244|PDB:5VDQ,ECO:0000244|PDB:5VDR,ECO:0000244|PDB:5VDS,ECO:0000244|PDB:5VDT,ECO:0000244|PDB:5VDU,ECO:0000244|PDB:5VDV,ECO:0000244|PDB:5VDW,ECO:0000244|PDB:6CT9,ECO:0000244|PDB:6CTA,ECO:0000244|PDB:6NAO,ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:24332030,ECO:0000269|PubMed:24462292,ECO:0000269|PubMed:28934246,ECO:0000269|PubMed:28940468,ECO:0000269|PubMed:30007416;Dbxref=PMID:23707061,PMID:24332030,PMID:24462292,PMID:28934246,PMID:28940468,PMID:30007416	
Q8N884	UniProtKB	Metal binding	404	404	.	.	.	Note=Zinc;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5V8H,ECO:0000244|PDB:5V8J,ECO:0000244|PDB:5V8O,ECO:0000244|PDB:5VDO,ECO:0000244|PDB:5VDP,ECO:0000244|PDB:5VDQ,ECO:0000244|PDB:5VDR,ECO:0000244|PDB:5VDS,ECO:0000244|PDB:5VDT,ECO:0000244|PDB:5VDU,ECO:0000244|PDB:5VDV,ECO:0000244|PDB:5VDW,ECO:0000244|PDB:6CT9,ECO:0000244|PDB:6CTA,ECO:0000244|PDB:6NAO,ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:24332030,ECO:0000269|PubMed:24462292,ECO:0000269|PubMed:28934246,ECO:0000269|PubMed:28940468,ECO:0000269|PubMed:30007416;Dbxref=PMID:23707061,PMID:24332030,PMID:24462292,PMID:28934246,PMID:28940468,PMID:30007416	
Q8N884	UniProtKB	Binding site	211	211	.	.	.	Note=GTP;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8C6L5	
Q8N884	UniProtKB	Binding site	213	213	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:6CTA,ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Binding site	319	319	.	.	.	Note=GTP;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:24462292;Dbxref=PMID:24462292	
Q8N884	UniProtKB	Binding site	362	362	.	.	.	Note=PF-06928215 inhibitor;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28934246;Dbxref=PMID:28934246	
Q8N884	UniProtKB	Binding site	376	376	.	.	.	Note=PF-06928215 inhibitor;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28934246;Dbxref=PMID:28934246	
Q8N884	UniProtKB	Binding site	414	414	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:6CTA,ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Site	140	141	.	.	.	Note=Cleavage%3B by CASP1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Site	157	158	.	.	.	Note=Cleavage%3B by CASP1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Site	187	187	.	.	.	Note=Important for preferential detection of curved long DNA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Site	195	195	.	.	.	Note=Important for preferential detection of curved long DNA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Modified residue	7	7	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q8N884	UniProtKB	Modified residue	143	143	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q8N884	UniProtKB	Modified residue	210	210	.	.	.	Note=(Microbial infection) Deamidated asparagine%3B by herpes simplex virus 1/HHV-1 UL37;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30092200;Dbxref=PMID:30092200	
Q8N884	UniProtKB	Modified residue	215	215	.	.	.	Note=Phosphotyrosine%3B by BLK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30356214;Dbxref=PMID:30356214	
Q8N884	UniProtKB	Modified residue	286	286	.	.	.	Note=5-glutamyl polyglutamate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8C6L5	
Q8N884	UniProtKB	Modified residue	314	314	.	.	.	Note=5-glutamyl glutamate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8C6L5	
Q8N884	UniProtKB	Modified residue	389	389	.	.	.	Note=(Microbial infection) Deamidated asparagine%3B by herpes simplex virus 1/HHV-1 UL37;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30092200;Dbxref=PMID:30092200	
Q8N884	UniProtKB	Modified residue	414	414	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q8N884	UniProtKB	Modified residue	451	451	.	.	.	Note=(Microbial infection) Deamidated glutamine%3B by herpes simplex virus 1/HHV-1 UL37;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30092200;Dbxref=PMID:30092200	
Q8N884	UniProtKB	Modified residue	454	454	.	.	.	Note=(Microbial infection) Deamidated glutamine%3B by herpes simplex virus 1/HHV-1 UL37;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30092200;Dbxref=PMID:30092200	
Q8N884	UniProtKB	Alternative sequence	445	447	.	.	.	ID=VSP_014388;Note=In isoform 2. VCT->RLY;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q8N884	UniProtKB	Alternative sequence	448	522	.	.	.	ID=VSP_014389;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q8N884	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_050811;Note=T->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14702039,ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs9352000,PMID:14702039,PMID:15489334	
Q8N884	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_033677;Note=P->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs610913,PMID:15489334	
Q8N884	UniProtKB	Mutagenesis	33	33	.	.	.	Note=No effect on type I IFN and RSAD2 induction. No effect on cleavage by CASP1. No effect on cleavage by CASP1%3B when associated with A-67%3B A-90 and A-95. Highly decreases cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-67%3B A-90%3B A-95 and A-140. Abolishes cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-67%3B A-90%3B A-95%3B A-140 and A-157. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Mutagenesis	67	67	.	.	.	Note=No effect on type I IFN and RSAD2 induction. No effect on cleavage by CASP1%3B when associated with A-33%3B A-90 and A-95. Highly decreases cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-33%3B A-90%3B A-95 and A-140. Abolishes cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-33%3B A-90%3B A-95%3B A-140 and A-157. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Mutagenesis	90	90	.	.	.	Note=No effect on type I IFN and RSAD2 induction. No effect on cleavage by CASP1%3B when associated with A-33%3B A-67 and A-95. Highly decreases cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-33%3B A-67%3B A-95 and A-140. Abolishes cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-33%3B A-67%3B A-95%3B A-140 and A-157. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Mutagenesis	95	95	.	.	.	Note=No effect on type I IFN and RSAD2 induction. No effect on cleavage by CASP1%3B when associated with A-33%3B A-67 and A-90. Highly decreases cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-33%3B A-67%3B A-90 and A-140. Abolishes cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-33%3B A-67%3B A-90%3B A-140 and A-157. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Highly decreases cleavage by CASP1 and enhances type I IFN and RSAD2 induction upon DNA virus infection. Abolishes cleavage by CASP1%2C enhances RSAD2 induction upon DNA virus infection but no effect on cleavage by CASP5%3B when associated with A-157. Highly decreases cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-33%3B A-67%3B A-90 and A-95. Abolishes cleavage by CASP1 and enhances RSAD2 induction upon DNA virus infection%3B when associated with A-33%3B A-67%3B A-90%3B A-95 and A-157. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Highly decreases cleavage by CASP1 and enhances type I IFN and RSAD2 induction upon DNA virus infection. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Mutagenesis	157	157	.	.	.	Note=No effect on type I IFN and RSAD2 induction. Highly decreases cleavage by CASP1 and enhances type I IFN and enhances RSAD2 induction upon DNA virus infection. Abolishes cleavage by CASP1%2C enhances RSAD2 induction upon DNA virus infection but no effect on cleavage by CASP5%3B when associated with A-140. Abolishes cleavage by CASP1%3B when associated with A-33%3B A-67%3B A-90%3B A-95 and A-140. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Highly decreases cleavage by CASP1 and enhances type I IFN and enhances RSAD2 induction upon DNA virus infection. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28314590;Dbxref=PMID:28314590	
Q8N884	UniProtKB	Mutagenesis	171	174	.	.	.	Note=Abolishes DNA-binding but does not affect translocation to the nucleus following treatment with etoposide%3B when associated with A-407. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30356214;Dbxref=PMID:30356214	
Q8N884	UniProtKB	Mutagenesis	171	171	.	.	.	Note=No effect on stimulation of interferon production. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23707061;Dbxref=PMID:23707061	
Q8N884	UniProtKB	Mutagenesis	173	173	.	.	.	Note=Strongly reduces enzyme activity and stimulation of interferon production%3B when associated with A-176. No effect on stimulation of interferon production. K->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:23722159,ECO:0000269|PubMed:24116191;Dbxref=PMID:23707061,PMID:23722159,PMID:24116191	
Q8N884	UniProtKB	Mutagenesis	173	173	.	.	.	Note=Strongly reduces stimulation of interferon production. K->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:23722159;Dbxref=PMID:23707061,PMID:23722159	
Q8N884	UniProtKB	Mutagenesis	174	174	.	.	.	Note=Strongly reduces enzyme activity and stimulation of interferon production. L->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23722159,ECO:0000269|PubMed:24116191;Dbxref=PMID:23722159,PMID:24116191	
Q8N884	UniProtKB	Mutagenesis	176	176	.	.	.	Note=Strongly reduces enzyme activity and stimulation of interferon production%3B when associated with A-173. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23722159;Dbxref=PMID:23722159	
Q8N884	UniProtKB	Mutagenesis	187	187	.	.	.	Note=Induces alteration of the DNA-binding surface and leads to increased synthesis of cyclic GMP-AMP (cGAMP)%3B when associated with R-195. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Mutagenesis	195	195	.	.	.	Note=Induces alteration of the DNA-binding surface and leads to increased synthesis of cyclic GMP-AMP (cGAMP)%3B when associated with N-187. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Mutagenesis	210	214	.	.	.	Note=Abolishes DNA-binding but does not affect translocation to the nucleus following treatment with etoposide%3B when associated with A-384. NTGSY->ATGSA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30356214;Dbxref=PMID:30356214	
Q8N884	UniProtKB	Mutagenesis	210	210	.	.	.	Note=More than 75%25 inhibition of interferon beta production. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30092200;Dbxref=PMID:30092200	
Q8N884	UniProtKB	Mutagenesis	211	211	.	.	.	Note=Abolishes enzyme activity%3B when associated with I-376 and I-436. T->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25131990;Dbxref=PMID:25131990	
Q8N884	UniProtKB	Mutagenesis	212	213	.	.	.	Note=Abolishes enzyme activity. Abolishes stimulation of interferon production. GS->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23722159;Dbxref=PMID:23722159	
Q8N884	UniProtKB	Mutagenesis	215	215	.	.	.	Note=Strongly reduced tyrosine phosphorylation. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30356214;Dbxref=PMID:30356214	
Q8N884	UniProtKB	Mutagenesis	215	215	.	.	.	Note=Phosphomimetic mutant%3B reduced translocation to the nucleus following treatment with etoposide. Y->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30356214;Dbxref=PMID:30356214	
Q8N884	UniProtKB	Mutagenesis	225	227	.	.	.	Note=Abolishes enzyme activity and stimulation of interferon production. Does not affect translocation to the nucleus following treatment with etoposide. EFD->AFA;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:23722159,ECO:0000269|PubMed:26229115,ECO:0000269|PubMed:30356214;Dbxref=PMID:23707061,PMID:23722159,PMID:26229115,PMID:30356214	
Q8N884	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Abolishes stimulation of interferon production%3B when associated with E-254 and E-327. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24462292;Dbxref=PMID:24462292	
Q8N884	UniProtKB	Mutagenesis	254	254	.	.	.	Note=Abolishes stimulation of interferon production%3B when associated with E-236 and E-327. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24462292;Dbxref=PMID:24462292	
Q8N884	UniProtKB	Mutagenesis	295	305	.	.	.	Note=Abolished nuclear localization. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30356214;Dbxref=PMID:30356214	
Q8N884	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Abolishes enzyme activity. Does not affect translocation to the nucleus following treatment with etoposide. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30356214;Dbxref=PMID:30356214	
Q8N884	UniProtKB	Mutagenesis	327	327	.	.	.	Note=Abolishes stimulation of interferon production%3B when associated with E-236 and E-254. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24462292;Dbxref=PMID:24462292	
Q8N884	UniProtKB	Mutagenesis	347	347	.	.	.	Note=Abolishes stimulation of interferon production. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24462292;Dbxref=PMID:24462292	
Q8N884	UniProtKB	Mutagenesis	353	353	.	.	.	Note=Abolishes stimulation of interferon production. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24462292;Dbxref=PMID:24462292	
Q8N884	UniProtKB	Mutagenesis	376	376	.	.	.	Note=Alters enzyme activity%2C leading to the appearance of 3'-5' linked cGAMP. Abolishes enzyme activity%3B when associated with Q-211 and I-436. R->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25131990;Dbxref=PMID:25131990	
Q8N884	UniProtKB	Mutagenesis	384	384	.	.	.	Note=Abolishes stimulation of interferon production. Abolishes DNA-binding but does not affect translocation to the nucleus following treatment with etoposide%3B when associated with 210-A--A-214. K->A%2CE;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:24116191,ECO:0000269|PubMed:30356214;Dbxref=PMID:23707061,PMID:24116191,PMID:30356214	
Q8N884	UniProtKB	Mutagenesis	390	390	.	.	.	Note=Strongly reduces stimulation of interferon production. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23707061;Dbxref=PMID:23707061	
Q8N884	UniProtKB	Mutagenesis	394	394	.	.	.	Note=Abolishes enzyme activity. No effect on stimulation of interferon production. K->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:24462292;Dbxref=PMID:23707061,PMID:24462292	
Q8N884	UniProtKB	Mutagenesis	394	394	.	.	.	Note=Abolishes enzyme activity. Abolishes stimulation of interferon production. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23707061;Dbxref=PMID:23707061	
Q8N884	UniProtKB	Mutagenesis	396	397	.	.	.	Note=Abolishes DNA binding and enzyme activity. Abolishes stimulation of interferon production. CC->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23722159;Dbxref=PMID:23722159	
Q8N884	UniProtKB	Mutagenesis	396	396	.	.	.	Note=Abolishes DNA binding and enzyme activity. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23707061;Dbxref=PMID:23707061	
Q8N884	UniProtKB	Mutagenesis	397	397	.	.	.	Note=Abolishes stimulation of interferon production. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23707061;Dbxref=PMID:23707061	
Q8N884	UniProtKB	Mutagenesis	400	400	.	.	.	Note=Abolishes stimulation of interferon production%3B when associated with E-403. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24116191;Dbxref=PMID:24116191	
Q8N884	UniProtKB	Mutagenesis	403	403	.	.	.	Note=Abolishes stimulation of interferon production%3B when associated with E-400. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24116191;Dbxref=PMID:24116191	
Q8N884	UniProtKB	Mutagenesis	404	404	.	.	.	Note=Abolishes stimulation of interferon production. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23707061;Dbxref=PMID:23707061	
Q8N884	UniProtKB	Mutagenesis	407	407	.	.	.	Note=Abolishes enzyme activity and stimulation of interferon production%3B when associated with A-411. Abolishes enzyme activity. Abolishes stimulation of interferon production. Abolishes DNA-binding but does not affect translocation to the nucleus following treatment with etoposide%3B when associated with 171-K--L-174 Del. K->A%2CE;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23707061,ECO:0000269|PubMed:23722159,ECO:0000269|PubMed:30356214;Dbxref=PMID:23707061,PMID:23722159,PMID:30356214	
Q8N884	UniProtKB	Mutagenesis	411	411	.	.	.	Note=Abolishes enzyme activity and stimulation of interferon production%3B when associated with A-407. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23722159;Dbxref=PMID:23722159	
Q8N884	UniProtKB	Mutagenesis	414	414	.	.	.	Note=Abolishes stimulation of interferon production. K->A%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23707061;Dbxref=PMID:23707061	
Q8N884	UniProtKB	Mutagenesis	434	434	.	.	.	Note=Gains susceptibility to mouse-specific RU.521%3B when associated with H-482. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Mutagenesis	436	436	.	.	.	Note=Abolishes enzyme activity%3B when associated with Q-211 and I-376. Y->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25131990;Dbxref=PMID:25131990	
Q8N884	UniProtKB	Mutagenesis	482	482	.	.	.	Note=Gains susceptibility to mouse-specific RU.521%3B when associated with C-434. N->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30007416;Dbxref=PMID:30007416	
Q8N884	UniProtKB	Beta strand	157	159	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	162	174	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Turn	175	178	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	180	197	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	201	203	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	207	210	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	212	216	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4MKP	
Q8N884	UniProtKB	Beta strand	220	222	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4O67	
Q8N884	UniProtKB	Beta strand	225	233	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	237	242	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	246	254	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	256	258	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5VDR	
Q8N884	UniProtKB	Helix	263	265	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	266	271	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V8H	
Q8N884	UniProtKB	Helix	273	288	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	292	294	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEW	
Q8N884	UniProtKB	Beta strand	296	298	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	304	306	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	308	312	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Turn	313	315	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	316	326	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	332	334	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Turn	341	344	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	346	353	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	357	361	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	364	366	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5VDP	
Q8N884	UniProtKB	Beta strand	369	371	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5VDP	
Q8N884	UniProtKB	Beta strand	375	378	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	380	388	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	391	393	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEW	
Q8N884	UniProtKB	Turn	394	397	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Beta strand	398	400	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	406	423	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	425	427	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Turn	429	432	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	435	448	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	452	455	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	457	459	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	460	477	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Turn	493	495	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	498	513	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
Q8N884	UniProtKB	Helix	518	521	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4LEV	
